Cancel

Hematologic Malignancies Demystified - Atlanta A Critical Appraisal of Data from 2018

Explore the options in hematology and hematologic malignancies with this live meeting. Stay informed on new data with established agents and gain insight into the use of novel agents in your practice. Expert faculty will focus on updates from recent congresses and the latest clinically relevant data.
This activity is provided by The University of Texas MD Anderson Cancer Center and prIME Oncology.

Hematologic Malignancies Demystified - Houston A Critical Appraisal of Data from 2018

Explore the options in hematology and hematologic malignancies with this live meeting. Stay informed on new data with established agents and gain insight into the use of novel agents in your practice. Expert faculty will focus on updates from recent congresses and the latest clinically relevant data.
This activity is provided by The University of Texas MD Anderson Cancer Center and prIME Oncology.

Melanoma: Updates from Brisbane, Australia The latest data in melanoma reported at the joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma

Roxana S. Dronca, MD, and Lisa A. Kottschade, APRN, MSN, CNP, offer their expert insights into recent data on advanced melanoma presented at a joint meeting of the 9th World Congress of Melanoma and 14th International Congress of the Society for Melanoma Research. Listen to what these experts have to say about combination therapy in the adjuvant setting for metastatic melanoma, real-world utilization of checkpoint inhibitor therapy, sequencing options for BRAF +/- MEK Inhibition following immu...
Annenberg Center for Health Sciences at Eisenhower

Optimizing Management of Carcinoid Syndrome in Patients With Neuroendocrine Tumors

STATEMENT OF NEED Carcinoid syndrome refers to a constellation of symptoms caused by the systemic release of humoral factors such as polypeptides, biogenic amines, and prostaglandins, mostly from well-differentiated neuroendocrine tumors. Patients frequently experience flushing, abdominal cramps, bronchospasms, hypotension, and diarrhea, which lead to impaired quality of life and daily functioning. In addition, complications such as carcinoid heart disease and mesenteric and/or retroperiton...
Postgraduate Institute for Medicine and i3 Health

Current Challenges and New Opportunities in Follicular Lymphoma

STATEMENT OF NEED Of the estimated 74,680 new cases of non-Hodgkin lymphoma each year in the United States, approximately 35% are follicular lymphoma (FL), an indolent, difficult-to-treat B-cell malignancy. Most patients are diagnosed at an average age of 65 years. Despite the introduction of novel therapies during the past decade, complications such as delayed presentation and treatment and evolving disease subtypes continue to hamper patient outcomes, and multiple recurrences with availab...
Postgraduate Institute for Medicine and i3 Health

Treatment Strategies in Chronic Leukemias and Introduction to CAR-T Therapy

Chronic lymphocytic (CLL) and chronic myelogenous (CML) leukemia are commonly diagnosed and treated by community oncologists. Whereas, in the past, these hematologic malignancies were considered incurable, new therapies have challenged that notion. Tyrosine kinase inhibitors (TKIs) annihilated the concept of CML as a poorly controlled disease, and most patients are now expected to live a normal life, with good quality of life. New testing procedures have suggested that some patients may be ...
Potomac Center for Medical Education, Postgraduate Institute for Medicine and Rockpointe Oncology

Payment Models and Practice Changes: Meeting Requirements of OCM & MACRA

Recent legislation and policy has fast-tracked the shift of healthcare payment from volume- to value-based reimbursement under the Medicare Access and CHIP Reauthorization Act (MACRA) for oncology care. Today, oncologists have the option to be reimbursed for Medicare patients under the CMS Oncology Care Model (OCM), an alternative payment model spanning a 6-month chemotherapy episode-of-care. This activity will provide insight into the program’s structure and challenges. It will also review ...
Potomac Center for Medical Education, Postgraduate Institute for Medicine and Rockpointe Oncology

Integrating Therapeutic Advances to Improve Current Practices in Myeloma Patient Care

Improving outcomes for patients with multiple myeloma requires building on the foundation of current therapies with new agents and combinations, recognizing the nature of each individual patient’s disease, and providing a personalized approach to treatment. This activity uses evidence-based presentations and case study vignettes to present the latest information on selecting the most appropriate therapy based on patient profile, clinical evidence, and assessment of risk-versus-benefit. Le...
Multiple Myeloma Research Foundation, RedMedEd, and Penn State College of Medicine

Orbital Oncology and Oncologic Oculofacial Plastic Surgery: A Multidisciplinary Approach

www.mdanderson.org/conferences
MD Anderson

Evidence-based Updates in Non-Hodgkin’s Lymphoma

Significant advances in treatment with novel agents for B-cell non-Hodgkin’s lymphoma (NHL) have improved patient outcomes and survival. However, many patients are at high-risk of relapse, meriting a precision approach to reduce the rate of recurrence and improve outcomes. The identification of molecular subtypes, the persistence of clinical challenges, and the anticipated emergence of clinical data necessitate a collaborative treatment approach to ensure individualized care for patients wit...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Integrating Immunotherapy for NSCLC

The emergence of checkpoint inhibitors (CTLA4, PD1, PD-L1) has reawakened an interest in immunotherapy to treat various malignancies. New agents have rapidly been approved for use in melanoma, bladder cancer, renal cell, lung cancer, and other malignancies. These agents have a unique toxicity profile requiring careful clinical assessment, rapid intervention, and aggressive management of side effects. This activity will provide a general overview of immunotherapy in cancer treatment, with a ...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, Rockpoointe Oncology

Improving Colorectal Cancer Prevention: Latest Advances to Improve Adenoma Detection Rates

Colorectal cancer (CRC) is the third most common type of cancer worldwide and second deadliest form of cancer in the United States. Current estimates suggest that up to 25% of adenomas are missed with current colonoscopy technologies, primarily due to poor visualization in folds and other difficult-to-detect areas. Technological advances in recent years have improved detection rates. This CME activity will review appropriate screening and prevention efforts for the early detection of patients ...
Slack Inc.

Checkpoint Inhibitors in Gastrointestinal Tumors: The Latest Evidence on Safety, Efficacy, and Biomarkers

The genomes of cancers deficient in mismatch repair (MMR) contain extremely high numbers of somatic mutations. Analysis of recent clinical studies have demonstrated that colorectal cancers with mismatch repair deficiency (dMMR) and other advanced dMMR cancers are sensitive to immune checkpoint blockade with PD-1 antibodies, and that mutational burden correlates with treatment response. These findings have led to the recent approval of two immune checkpoint inhibitors for the treatment of micro...
Slack Inc.

Navigating New Options to Improve Outcomes in Multiple Myeloma

As new combinations and classes of agents emerge for the treatment of multiple myeloma (MM), community-based treatment teams require clarity on the optimal integration of recently approved and emerging agents into the relapsed/refractory landscape for MM. While high-dose chemotherapy is not appropriate for all patients, multiple options have emerged that demonstrate a clinical benefit and require proper integration into the treatment paradigm. In addition, clinicians must meet requirements for...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Targeted Therapy for Skin Malignancies: Basal Cell Carcinoma, Melanoma, and Merkel Cell

Patients may not always be offered the most appropriate single and combination targeted therapies that have been proven effective in clinical trials. Currently available clinical data have practice-changing implications for medical oncologists, dermatologists, and related specialists treating skin malignancies. To stay up to date with the latest data, evidence will be presented related to the role of BRAF inhibition, hedgehog signaling, and immunotherapy in the pathogenesis and treatment of ba...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Advancing Standards in the Management of Hemophilia A: Contemporary Strategies and Innovations

The US health care ecosystem has undergone a profound transformation in recent years, with far-reaching implications for patients with hemophilia A. Clinical management of patients with hemophilia has become increasingly complex due to the introduction of new treatment strategies, the presence of comorbidities related to hemophilia, and the increased emphasis on outcomes such as quality of life, to balance both the medical and lifestyle consequences of the disease. Patients with severe hemophi...
CMEology

The Oncologist: The Challenges of Validating in Precision Medicine: The Case of ERCC1 Diagnostic Testing

Learning Objectives: 1. Describe the obstacles to the successful translation of predictive/prognostic molecular cancer biomarkers to the clinic. 2. Explain the importance of prospective design and good study reporting in predictive/prognostic cancer marker development. 3. Discuss the way poor study design and coordination can impede rapid biomarker validation in cancer. Personalized medicine relies upon the successful identification and translation of predictive biomarkers. Unfortunately...
Society For Translational Oncology

The Oncologist: Does a Higher Cutoff Value of Lymph Node Retrieval Substantially Improve Survival in Patients With Advanced Gastric Cancer?—Time to Embrace a New Digit

Learning Objective: 1. Describe the ways in which adequate LN dissection improves long-term survival without compromising patient safety. Background. The present study assessed the impact of the retrieval of >25 lymph nodes (LNs) on the survival outcome of patients with advanced gastric cancer after curative‐intent gastrectomy. Patients and Methods. A total of 5,386 patients who had undergone curative gastrectomy for gastric cancer from 1994 to 2011 were enrolled. The clinicopatholo...
Society For Translational Oncology

Precision Medicine and Impact of Therapeutic Drug Levels

Much has been written recently about the need for genetic testing and biomarkers to identify specific targets within cancers, recognizing that there are many subclones and individual differences within the malignancies that arise in patients, even in those with morphologically similar cancers. Another important aspect of cancer treatment is the need to optimize the dose and schedule of administered therapies. Pharmacogenomics has demonstrated that the bioavailability and half-lives of anti-ca...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Targeting EGFR, T790M, ALK, and ROS1 in NSCLC

Oncology treatment teams are tasked with navigating through a steady increase in the number and complexity of molecular biomarkers that guide treatment decisions. FDA-approved companion tests have expanded testing options and provide uniformity of reporting, yet challenges in the clinical setting and the potential to negatively impact patient outcomes persist. As part of the continuum of care in oncology, there is an increasing demand for genomic testing to guide the course of treatment. Misi...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

The Oncologist: The Impact of an Educational Program on Patient Practices for Safe Use, Storage, and Disposal of Opioids at a Comprehensive Cancer Center

Learning Objectives: 1. Describe the problem of opioid abuse as it relates to knowledge of patients regarding proper use, storage, and disposal of opioids. 2. Describe the process undergone by the outpatient supportive care clinic described in the article to implement an opioid education program in order to address gaps in patient knowledge. Background. Improper use, storage, and disposal of prescribed opioids can lead to diversion or accidental poisoning. Our previous study showed a lar...
Society For Translational Oncology

The Oncologist: A Study of Thymidylate Synthase Expression as a Biomarker for Resectable Colon Cancer – Alliance (CALGB) 9581 and 89803

Learning Objectives: 1. Describe the association between tumor levels of thymidylate synthase and outcomes in patients with resected colon cancer treated with adjuvant therapy 2. Discuss the value of thymidylate synthase levels in predicting treatment benefits of 5-fluorouracil in patients with resected colon cancer Purpose. Tumor levels of thymidylate synthase (TS), a target of 5‐fluorouracil (5‐FU)‐based chemotherapy for colorectal cancer, have been studied as a predictive or pro...
Society For Translational Oncology

Ace the Case: A 35-Year-Old Man Presents to a Dermatologist with a Brown Pigmented Lesion That Has Been Changing Over the Past 3 Months

This educational activity will utilize a case study to discuss the diagnosis and management of a 35-year-old man who has a brown pigmented lesion that has been changing over the past 3 months.
Slack Inc.

Penn Radiology Oncologic Imaging: Optimizing Patient Care (Streaming Online & DVD-ROM)

Penn Radiology joins forces with its experts in Nuclear Medicine, Gastroenterology, Pulmonology, Radiation and Interventional Oncology to present this comprehensive review of Oncologic Imaging. Best practices and clinical correlates will be discussed, with two detailed sessions dedicated to CT screening for lung cancer. Credits for this program can be applied toward your Self Assessment CME Requirements for ABR Maintenance of Certification. Topics: CT Screening for Lung Cancer, State of th...
Meetings By Mail®

Medical Oncology and Hematology 2019: Multidisciplinary Approaches that Improve Coordination of Care

www.mdanderson.org/conferences
MD Anderson

Clinical and Multidisciplinary Hematology and Oncology 2019 : The 16th Annual Review

This course will include a comprehensive update and management strategies of issues in hematologic and oncologic malignancies presenting new disease classification, treatment, and challenging cases. Course topics will focus on hematologic diseases, solid tumors and overlap topics of supportive, ancillary and diagnostic care. The course offers challenging and interactive sessions on pertinent issues involved with the care of patients.
Mayo Clinic

Metastatic Breast Cancer

While mortality rates for breast cancer are decreasing, metastatic breast cancer (MBC) remains incurable. This session will review new treatment options based on molecular and genetic information, the level of evidence used to formulate practice guidelines, as well as updates from ASCO 2017. New agents, including PARP inhibitors for those with appropriate mutations, will also be discussed. Clinically-oriented guidelines on the management of MBC were developed by the European Society for Medica...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Redefining Care for BRCA and Other Familial-associated Cancers

Advances in molecular genetics and testing have refined the diagnosis, treatment, and follow-up for patients with BRCA and other familial genetic syndromes. As women with germline BRCA1 and BRCA2 mutations are at an increased risk for developing high-grade serous ovarian cancer, there are implications for genetic testing, family counseling, radiologic screening, and pharmaceutical choices in the community setting. Molecular and genetic advances, such as novel PARP inhibitors, are altering the ...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Rheumatic Immune-related Adverse Events: Multidisciplinary Perspectives on Recognition and Management

The introduction of immune checkpoint inhibitors has had a great impact on the field of oncology. However, these new therapies are associated with a spectrum of autoimmune and systemic inflammatory reactions known as immune-related adverse events (irAEs). Rheumatologists are likely to encounter a wide variety of irAEs as the use of immune checkpoint inhibitors expands in the treatment of several cancers. Thus, it is critical for rheumatologists to be aware of these complications to accurately ...
Slack Inc.

Immune Checkpoint Inhibitors for Bladder Cancer: Practice Essential for Community Oncologists and Advanced Practice Providers

For many years, the mainstay of initial treatment for metastatic bladder cancer has been chemotherapy. However, immunotherapy with PD-1/PD-L1 checkpoint inhibitors is revolutionizing the treatment of bladder cancer. Currently, 5 checkpoint inhibitors are approved for patients who have failed prior platinum-based chemotherapy or are ineligible for cisplatin-based chemotherapy. In this CME activity, expert faculty will assess the clinical evidence regarding the efficacy, safety, and tolerability...
Slack Inc.

Use of Oncology Quality Measures Where Do We Go from Here?

The new CMMI guidelines for physician reimbursement for patient care require some demonstration of quality and value in care delivery. Certain quality programs are available to oncologists (such as PQRS, QOPI, etc.). These assessments of quality require demonstration that specific guidelines are measured and followed within acceptable compliance targets. This session will address how these measures are developed and applied for use in the new payment models.
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Achieving Precision Care in Gastrointestinal Cancers

Treatment selection is largely dependent on the goals of therapy; however, sequencing of standard therapies with newly approved therapies as patients’ progress is a key factor in improving quality of care. The recent approval of new agents and advances in biomarker detection have supported the individualization of treatment and subsequent improvements in survival for patients with gastrointestinal cancers. As new agents are expected to enter the treatment paradigm in 2017, clinicians will r...
The Potomac Center for Medical Education, Postgraduate Institute for Medicine, and Rockpointe Oncology.

Integrating New Therapies into Treatment Regimens for Gastric and Gastroesophageal Cancer

The recent inclusion of targeted biologic agents in guideline recommendations has provided oncologists with more treatment options and patients with the potential for improved outcomes. However, these additional options also increase the complexity of treatment selections and appropriate sequencing of treatments for patients with gastric and gastroesophageal (GEJ) cancers. Integrating New Therapies into Treatment Regimens for Gastric and Gastroesophageal Cancer will guide community clinicians...
The Potomac Center for Medical Education

Advances in Colorectal Cancer – From Screening to Innovative Care

Colorectal cancer is the #2 cause of cancer death in North America. While we successfully screen for colorectal cancer, many gaps in evidence-based treatment remain. Current practitioners have questions about the role of circulating tumor DNA in the diagnosis and management of early to advanced colorectal cancer; the role of endoscopic microsurgery in the management of colon cancer; and when full oncologic surgery is required to deliver the most appropriate care for colon cancer. For patients ...
Virginia Mason

Neuro/ENT: Review and Update

This course is designed as a state-of-the-art imaging review of case material that affects the brain, spine, and head and neck. The internationally known faculty has chosen subject material that emphasizes their approach to solving clinically relevant problems involving these areas. Whether an experienced radiologist or one newly introduced to this material, this course will improve your ability to analyze CT and MR images and to offer a pertinent differential diagnosis.
iiCME

Ace the Case: A 48-Year-Old Woman Confused About a Diagnosis of Leukemia

This “Ace the Case” activity will utilize a case study to discuss the assessment and management of a 48-year-old woman with a myeloproliferative disorder. Accurately assess the appropriate treatment option(s) for this patient for CME credits.
Slack Inc.

The Oncologist: Aspirin is Associated with Improved Survival in Severely Thrombocytopenic Cancer Patients with Acute Myocardial Infarction

Learning Objectives: 1. Describe the relationship between severe thrombocytopenia and mortality in patients with AMI and hematologic malignancies. 2. Discuss the effect of aspirin therapy on patients with AMI and severe thrombocytopenia. Background. Patients with hematologic malignancies are at risk for severe thrombocytopenia (sTP). The risk and benefit of aspirin are not known in thrombocytopenic cancer patients experiencing acute myocardial infarction (AMI). Materials and Methods. ...
Society For Translational Oncology

Advances in Radioactive Iodine-Refractory Differentiated Thyroid Cancer

Patients with radioactive iodine-refractory thyroid cancer (RAIR-DTC) have poor prognoses and, until recently, there were no effective targeted systemic therapies available for RAIR-DTC. Targeted therapies sorafenib and lenvatinib have been approved by the FDA for treating RAIR-DTC in the last 5 years. Along with these approved therapies, other targeted therapies, such as cabozantinib and vandetanib, which were approved earlier in the decade by the FDA for treating medullary thyroid cancer, ar...
The Endocrine Society, Rockpointe Oncology

Optimizing Patient Outcomes in Castration-Resistant Prostate Cancer: Moving Urologists From Knowledge to Action

Evan Ya-Wen Yu, MD, provides his insights into the evolving management of patients with castration-resistant prostate cancer (CRPC) and the implications of the genomic landscape on CRPC. Since clinical trial evidence does not clearly inform sequencing strategies, Dr. Yu weaves his insight into this conundrum using 3 cases, with suggestions to help the urologist individualize treatment. CONTENT AREAS • National Comprehensive Cancer Network guidelines on prostate cancer • Clinical tria...
Annenberg Center for Health Sciences at Eisenhower

Advances in the Multidisciplinary Management of Hepatocellular Carcinoma (HCC): Strategies for Incorporating Emerging Immunotherapy Treatment Options

Expert faculty, Richard Finn, MD, discusses treatment options and strategies in a case-based approach for two patients who have failed conventional therapies and may be candidates for immunotherapy. The activity features an online virtual patient platform that affords clinicians an opportunity to absorb relevant clinical and evidence-based information. The purpose of the activity is to inform clinicians on integrating immunotherapy into treatment options of advanced hepatocellular carcinoma pa...
ACHL

Obstetrics and Gynecology 2019

New Diagnosis and Treatment Updates in Clinical Obstetrics, Minimally Invasive Gynecologic Surgery, Urogynecology, Gynecologic Oncology, Reproductive Endocrinology, and Infertility This special update on diagnosis and treatment of reproductive health conditions in women, designed and presented by Harvard Medical School’s leading faculty and master clinicians, ensures you are current with the latest advances in obstetrics and gynecology. One of the highest-rated Harvard Medical School CME ...
Harvard Medical School

3rd Annual Therapeutic Advances for Advanced Practice Providers and Nurses: Hematology/Oncology Patient Care and Challenges 2019

Mayo Clinic's 3rd Annual Therapeutic Advances for Advanced Practice Providers and Nurses: Hematology/Oncology Patient Care and Challenges 2019 will be held in Jacksonville, Florida. This continuing medical education (CME) conference will focus on the needs of advanced practice providers, nurse practitioners, ARNPs (APRN), and nurses regarding the care of patients with hematologic and oncologic malignancies. The course will feature lectures, case presentations, panels discussions, interactive g...
Mayo Clinic

Multidisciplinary Management of Breast Cancer During Pregnancy

Learning Objectives: 1. Describe the method of determining the appropriate timing of surgery and regimen of chemotherapy for patients with BCDP. 2. Compare the dosing of chemotherapy for pregnant and non-pregnant patients. 3. Cite treatments contraindicated in BCDP. 4. Discuss the recommended supportive-care drugs and imaging approaches best suited to patients with BCDP. Background. Although breast cancer during pregnancy (BCDP) is rare (occurring with only 0.4% of all BC diagnoses i...
Society For Translational Oncology

The Oncologist:Management of Cancer in the Older Age Person: An Approach to Complex Medical Decisions

Learning Objectives: 1. Describe the proper approach to elderly cancer patients from the clinician’s point of view. 2. Discuss novel treatments and management approaches to elderly cancer patients based on their functional ages and their social and emotional needs. 3. Perform assessment of physiologic age. 4. Interpret “rapid learning” databases in the treatment of older cancer patients. Background The management of cancer in older aged people is becoming a common problem due to ...
Society For Translational Oncology

The Oncologist:Population-Level Differences in Rectal Cancer Survival in Uninsured Patients Are Partially Explained by Differences in Treatment

Learning Objectives: 1. Discuss the effect of insurance with Medicaid or lack of insurance on survival rates of rectal cancer. 2. Identify the reasons for lower survival in uninsured patients and strategies for improving survival in those patients. Background. Rectal cancer (RC) is a common malignancy with a substantial mortality but good survival for patients with optimally treated nonmetastatic disease. Lack of insurance may compromise access to care and therefore compromise survival...
Society For Translational Oncology

Improving Metastatic Colorectal Cancer (mCRC) Care in Community Cancer Centers

The clinical management of patients with metastatic colorectal cancer (mCRC) continues to evolve as advances in research lead to new approaches in molecular biomarker testing and the application of treatment plans that are tailored for each patient. The goal of this program is to educate and enable members of the cancer care team to apply the latest guidelines and evidence when managing patients with mCRC.
American Academy of CME

Clinical Strategies for Incorporating Immunotherapy in Advanced Breast Cancer: Insights for Surgeons and Oncologists

Six expert faculty discuss advances in immunotherapy as it relates to breast cancer. This interview-style format is based on follow-up coverage from the “Immunotherapy and Breast Cancer” symposium at the Society of Surgical Oncology 2018 Annual Cancer Symposium, held on March 23, 2018 in Chicago, Illinois. PowerPoint slides from the symposium, as well as a written transcript of the interviews, are available for download.
The Academy for Continued Healthcare Learning (ACHL) and Society of Surgical Oncology (SSO)

Thoracic Imaging - 2016: Society of Thoracic Radiology Clinical Update

Topics covered in Thoracic Imaging - 2016 include: Diffuse Lung Disease, Pulmonary Arteries, Aorta, Lung Nodule, Lung Cancer, Lung Cancer Screening, Thoracic Oncology, Cardiac Imaging, Coronary Imaging, Pulmonary Infection, Mediastinum, Pleura, COPD, Airways and many others. Reviewing Thoracic Imaging - 2016 will help you to better: • Recognize basic concepts in imaging interpretation including pitfalls, anatomic variants and frequently missed diagnoses • Discuss the role of imaging in...
CMEInfo

Hematology/Oncology & Cardiorespiratory/Renal Physiology and Medicine Eastern Caribbean Cruise

TBA
Continuing Education, Inc

12-Night Israel CME Land Tour - Internal Medicine, Breast Cancer & Medical-Legal Updates

Join Sea Courses on this spectacular land trip and immerse yourself in history! On several of the days there will be two options of tours to choose from. With high-end accommodations, English-speaking expert guides, exciting excursions and most meals included, this trip is sure to be spectacular!
CME AWAY by Sea Courses

RXinsider, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps. RXinsider, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map.